Literature DB >> 6851016

Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study.

H Acquatella, N B Schiller, J J Puigbó, J R Gómez-Mancebo, C Suarez, G Acquatella.   

Abstract

Ten patients (six women and four men) with endomyocardial disease, four with and six without hypereosinophilia, were studied by two-dimensional echocardiography (2-D echo). Eight had biventricular congestive heart failure and two had atypical chest pain with ischemic electrocardiographic changes. The patients were 15-50 years old (mean 40 years) and duration of illness was 2-9 years (mean 4.4 years). Nine had cardiac catheterization and three pathologic examination. Characteristic 2-D echo findings included apical obliteration of one or both ventricles by echogenic material suggestive of fibrosis or thrombosis; bright, specular echoes at the cavity surface of the apical obliteration suggesting patchy calcification; preserved left apical systolic inward motion, which differed significantly from the dyskinetic motion of thrombotic apical obliteration of ischemic or Chagasic origin (p less than 0.001); involvement of the papillary muscles and posterior atrioventricular valve; preserved ventricular contractile function in most patients; and the combination of normal-to-small ventricles with large atria. None of 14 subjects with secondary hypereosinophilia followed for 15.4 months developed similar 2-D echo findings. We conclude that both forms of endomyocardial disease had a 2-D echo pattern useful for noninvasive recognition and differentiation from patients who have valvular heart disease, constrictive pericarditis and cardiomyopathies of other origins.

Entities:  

Mesh:

Year:  1983        PMID: 6851016     DOI: 10.1161/01.cir.67.6.1219

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

Review 1.  Medical imaging.

Authors:  L Kreel
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

Review 2.  Endomyocardial fibrosis: still a mystery after 60 years.

Authors:  Gene Bukhman; John Ziegler; Eldryd Parry
Journal:  PLoS Negl Trop Dis       Date:  2008-02-27

3.  Eosinophilic Endomyocardial Fibrosis and Strongyloides stercoralis: A Case Report.

Authors:  Zahra Alizadeh-Sani; Anoushiravan Vakili-Zarch; Majid Kiavar; Behdad Bahadorian; Abas Nabavi
Journal:  Res Cardiovasc Med       Date:  2013-05-20

4.  Endomyocardial involvement in asymptomatic sub-Saharan immigrants with helminth-related eosinophilia.

Authors:  Cristina Carranza-Rodríguez; Daniel San-Román-Sánchez; Héctor Marrero-Santiago; Michele Hernández-Cabrera; Carlos Gil-Guillén; Elena Pisos-Álamo; Nieves Jaén-Sánchez; José-Luis Pérez-Arellano
Journal:  PLoS Negl Trop Dis       Date:  2017-02-24

5.  Characterization of Cardiopulmonary Exercise Testing Variables in Patients with Endomyocardial Fibrosis after Endocardial Resection.

Authors:  Ana Luiza C Sayegh; Marcelo R Dos Santos; Patricia de Oliveira; Fábio Fernandes; Eduardo Rondon; Francis R de Souza; Vera M C Salemi; Maria Janieire de N N Alves; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2017-12       Impact factor: 2.000

6.  Endomyocardial fibrosis in Sudan: clinical and echocardiographic features.

Authors:  Siddiq Ibrahim Khalil; Suha Khalil; Salma El Tigani; Hanan A Saad
Journal:  Cardiovasc J Afr       Date:  2017 Jul/Aug       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.